NXI Therapeutics Revenue

Biotechnology Research • Basel, Basel, Switzerland • 1-10 Employees

NXI Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	$4,000,000

Key Contact at NXI Therapeutics

Ruben Herrendorff

CEO at NXI Therapeutics

Company overview

Headquarters	Spitalstrasse 41, 10.094, Basel, Basel Stadt 4056, CH
Phone number	+41612077110
Website	nxitherapeutics.com
NAICS	541714
Founded	2021
Employees	1-10
Socials

NXI Therapeutics Email Formats

NXI Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@nxitherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@nxitherapeutics.com	100%

About NXI Therapeutics

NXI therapeutics focuses on the research and development of a new generation of selective immunosuppressive drugs for autoimmune diseases and transplantations - with objectives of high efficacy, good safety without adverse effects as seen with conventional immunosuppressants.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Funding Data

Explore NXI Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-07-18	2	$4,000,000

Funding Insights

$4,000,000

Total funding amount

$4,000,000

Most recent funding amount

Number of funding rounds

NXI Therapeutics Tech Stack

Discover the technologies and tools that power NXI Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Windows Server

Operating systems

Open Graph

Miscellaneous

Font Awesome

Font scripts

React

JavaScript frameworks

IIS

Web servers

PWA

Miscellaneous

Microsoft ASP.NET

Web frameworks

Google Maps

Maps

cdnjs

CDN

Microsoft 365

Frequently asked questions

NXI Therapeutics is located in Basel, Basel, CH.

You can reach NXI Therapeutics at +41612077110.

NXI Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

NXI Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NXI Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

NXI Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

NXI Therapeutics has raised a total of $4,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at NXI Therapeutics

Ruben Herrendorff

CEO at NXI Therapeutics

4.8

40,000 users